Table 2.
Marker | Primer combination | Fragment size (bp) | Frequency | p-value (x2) | |
---|---|---|---|---|---|
| |||||
High-IMF | Low-IMF | ||||
AFLP1 | E-ACC/T-CCG | 223 | 0.25 | 0.45 | 0.0157 |
AFLP2 | E-ACG/T-CTG | 71 | 0.30 | 0.48 | 0.0230 |
AFLP3 | E-AGC/T-CCA | 167 | 0.15 | 0.43 | 0.0013 |
AFLP4 | E- AGC/T-CTG | 136 | 0.48 | 0.28 | 0.0106 |
AFLP5 | E- AGG/T-CAT | 84 | 0.18 | 0.35 | 0.0574 |
AFLP6 | E- AGG/T-CCA | 188 | 0.03 | 0.20 | 0.0230 |
AFLP7 | E-ATC/T-CGT | 79 | 0.05 | 0.28 | 0.0069 |
AFLP8 | E-ATC/T-CGA | 176 | 0.50 | 0.18 | <0.0001 |
AFLP9 | E-ACG/T-CTG | 152 | 0.15 | 0.35 | 0.0268 |
AFLP10 | E-AGC/T-CTG | 171 | 0.05 | 0.23 | 0.0336 |
AFLP11 | E-ATC/T-CGA | 198 | 0.15 | 0.45 | 0.0003 |
AFLP12 | E-ACG/T-CTG | 145 | 0.10 | 0.28 | 0.0500 |
AFLP, amplified fragment length polymorphism; IMF, intramuscular fat.